Detalhe da pesquisa
1.
Personalizing health care: feasibility and future implications.
BMC Med
; 11: 179, 2013 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23941275
2.
Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe.
Appl Health Econ Health Policy
; 21(4): 537-546, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897550
3.
The challenge of ensuring elderly people can access their health insurance entitlements: a mixed methods study on the Republic of Srpska's Protector of Patients' Health Insurance Entitlements.
BMJ Glob Health
; 7(Suppl 6)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109016
4.
Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States.
Croat Med J
; 52(2): 183-97, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21495202
5.
Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer.
Eur J Health Econ
; 22(3): 393-403, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33438133
6.
Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe.
Appl Health Econ Health Policy
; 19(6): 915-927, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34553334
7.
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Expert Rev Pharmacoecon Outcomes Res
; 21(4): 527-540, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535841
8.
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures.
Front Pharmacol
; 11: 591134, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33519450
9.
Integrative Review of Managed Entry Agreements: Chances and Limitations.
Pharmacoeconomics
; 38(11): 1165-1185, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32734573
10.
Health care needs, utilization and barriers in croatia--regional and urban-rural differences.
Coll Antropol
; 33 Suppl 1: 121-30, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19563157
11.
Translation of evidence-based tobacco use prevention programming in Croatia.
Eval Health Prof
; 31(3): 297-305, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18566160
12.
Health care funding reforms in Croatia: a case of mistaken priorities.
Health Policy
; 80(1): 144-57, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16621119
13.
Use of preventive health care services among the unemployed in Croatia.
Croat Med J
; 48(5): 667-74, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17948952
14.
Association of social roles, health, and health behavior of elderly women in Croatia.
Croat Med J
; 48(5): 684-90, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17948954
15.
Croatian 2008-2010 health insurance reform: hard choices toward financial sustainability and efficiency.
Croat Med J
; 53(1): 66-76, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22351581
16.
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.
Pharmacoeconomics
; 35(12): 1271-1285, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28836222
17.
Importance of health care issues in 2005 presidential elections in Croatia.
Croat Med J
; 47(3): 499-502, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16758530
18.
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.
Front Pharmacol
; 5: 106, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24987370
19.
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.
Front Pharmacol
; 5: 109, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24959145
20.
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Front Pharmacol
; 4: 39, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23717279